Pfizer Inc (NYSE:PFE)

Data as of Aug 22
 +0.10 / +0.35%
Today’s Change
Today|||52-Week Range
Bristol-Myers/Pfizer's Eliquis Gets Yet Another FDA Nod - Analyst Blog
Aug 22 /
Stock Market News for August 15, 2014 - Market News
Aug 15 /
3 Reasons Bristol-Myers Squibb's Stock Could Rise
Aug 22 /
Pfizer's Prevnar 13 Backed by U.S. Panel for Expanded Use - Analyst Blog
Aug 14 /
3 Stocks Reiterated As A Buy: PFE, SLB, V
Aug 22 /
7 things you absolutely must know about corporate taxes
Aug 14 /
Pfizer Inc. (PFE): New Analyst Report from Zacks Equity Research - Zacks Equity Resea...
Aug 22 /
Athersys Loss In Line with Expectations, Revenues Down Y/Y - Analyst Blog
Aug 13 /
Markets Continue To Rally Ahead Of Yellen's Speech At Jackson Hole
Aug 21 / Benzinga
Big businesses still fighting for same-sex marriage
Aug 12 /
Astellas-Basilea's Isavuconazole Accepted for EU Review - Analyst Blog
Aug 21 /
UBS AG Contemplates $4.5B Bond Offerings in U.S. - Analyst Blog
Aug 12 /
US TV takeovers threaten UK creative economy, says C4 chief
Aug 21 /
5 Things Pfizer Inc.'s Management Wants You to Know
Aug 12 /
Build A bWhatever Happensb Portfolio Now
Aug 21 / Investing Channel
US groups ponder the great tax escape
Aug 08 /
Pfizer Could Revive AstraZeneca Bid As Early As Tuesday
Aug 21 / Benzinga
Tesla settles dispute with trademark troll in China
Aug 08 /
Drugmaker link-up puts Astra on top
Aug 21 /
How to stay safe in a scary market
Aug 07 /
Why AstraZeneca (AZN) Stock Is Higher Today
Aug 21 /
Shire shares slide on fears of 'tax inversion' clampdown
Aug 06 /
Healthcare Enjoys Growth Trends: 3 Medical Stocks to Buy - Analyst Blog
Aug 20 /
Corporate acquirors take early aim at their target's investors
Aug 05 /
Baxter International Expands Dialyzers Facility in Alabama - Analyst Blog
Aug 20 /
AstraZeneca chairman Leif Johansson defends Pfizer rebuff
Aug 04 /
What next for M&As now the bubble has burst?
Aug 20 /
AstraZeneca raises full-year earnings guidance
Jul 31 /
Pfizer Submits Palbociclib Marketing Application to the FDA - Analyst Blog
Aug 19 /
Pfizer refuses to rule out tax inversion deals
Jul 30 /
A Beaten-Up Pharma With a Big Upside
Aug 19 / Investing Channel
AstraZeneca to bolster respiratory drugs with Almirall deal
Jul 30 /
3 Reasons Pfizer Inc.'s Stock Could Rise
Aug 19 /
Stocks: 5 things to know before the open
Jul 29 /
DoJ closes AstraZeneca probe without bringing charges
Aug 19 /
Consumer and pharma groups swap assets
Jul 28 /
3 Stocks Reiterated As A Buy: PFE, XOM, REGN
Aug 18 /
Obama's dilemma over tax inversions
Jul 24 /
Pfizer Announces Submission of Palbociclib New Drug Application To The FDA
Aug 18 / Benzinga

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.